26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Providing a conceptual framework for HIV prevention cascades and assessing feasibility of empirical measurement with data from east Zimbabwe: a case study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          The HIV treatment cascade illustrates the steps required for successful treatment and is a powerful advocacy and monitoring tool. Similar cascades for people susceptible to infection could improve HIV prevention programming. We aim to show the feasibility of using cascade models to monitor prevention programmes.

          Methods

          Conceptual prevention cascades are described taking intervention-centric and client-centric perspectives to look at supply, demand, and efficacy of interventions. Data from two rounds of a population-based study in east Zimbabwe are used to derive the values of steps for cascades for voluntary medical male circumcision (VMMC) and for partner reduction or condom use driven by HIV testing and counselling (HTC).

          Findings

          In 2009 to 2011 the availability of circumcision services was negligible, but by 2012 to 2013 about a third of the population had access. However, where it was available only 12% of eligible men sought to be circumcised leading to an increase in circumcision prevalence from 3·1% to 6·9%. Of uninfected men, 85·3% did not perceive themselves to be at risk of acquiring HIV. The proportions of men and women tested for HIV increased from 27·5% to 56·6% and from 61·1% to 79·6%, respectively, with 30·4% of men tested self-reporting reduced sexual partner numbers and 12·8% reporting increased condom use.

          Interpretation

          Prevention cascades can be populated to inform HIV prevention programmes. In eastern Zimbabwe programmes need to provide greater access to circumcision services and the design and implementation of associated demand creation activities. Whereas, HTC services need to consider how to increase reductions in partner numbers or increased condom use or should not be considered as contributing to prevention services for the HIV-negative adults.

          Funding

          Wellcome Trust and Bill & Melinda Gates Foundation.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          HIV decline associated with behavior change in eastern Zimbabwe.

          Few sub-Saharan African countries have witnessed declines in HIV prevalence, and only Uganda has compelling evidence for a decline founded on sexual behavior change. We report a decline in HIV prevalence in eastern Zimbabwe between 1998 and 2003 associated with sexual behavior change in four distinct socioeconomic strata. HIV prevalence fell most steeply at young ages-by 23 and 49%, respectively, among men aged 17 to 29 years and women aged 15 to 24 years-and in more educated groups. Sexually experienced men and women reported reductions in casual sex of 49 and 22%, respectively, whereas recent cohorts reported delayed sexual debut. Selective AIDS-induced mortality contributed to the decline in HIV prevalence.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Optimizing the engagement of care cascade: a critical step to maximize the impact of HIV treatment as prevention.

            At present, data from mathematical models, ecologic studies and a clinical trial demonstrate that use of combination antiretroviral therapy (cART) can markedly reduce HIV transmission. Expansion of cART uptake (Treatment as Prevention) is a critical component of biomedical interventions to prevent HIV transmission. Successful implementation is dependent on identifying undiagnosed individuals, linking and retaining them in care and initiating durable and potent cART regimens. This continuum is encapsulated within the framework of the 'Test and Treat', or 'Seek, Test, Treat and Retain' strategies. Currently only 19-28% of all HIV-infected individuals in the USA are estimated to be virologically suppressed. Optimizing the engagement of care cascade represents a critical step to maximize the individual and societal impact of cART and therefore deliver on the promise of HIV Treatment as Prevention.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis.

              Male circumcision provides long-term indirect protection to women by reducing the risk of heterosexual men becoming infected with HIV. In this Review, we summarise the evidence for a direct effect of male circumcision on the risk of women becoming infected with HIV. We identified 19 epidemiological analyses, from 11 study populations, of the association of male circumcision and HIV risk in women. A random-effects meta-analysis of data from the one randomised controlled trial and six longitudinal analyses showed little evidence that male circumcision directly reduces risk of HIV in women (summary relative risk 0.80, 95% CI 0.53-1.36). Definitive data would come from a further randomised controlled trial of circumcision among men infected with HIV in serodiscordant heterosexual relationships, but this would involve enrolling about 10 000 couples and is likely to be logistically unfeasible. As circumcision services for HIV prevention are scaled-up in high HIV prevalence settings, rapid integration with existing prevention strategies would maximise benefits for both men and women. Rigorous monitoring is essential to ensure that any adverse effects on women are detected and minimised.
                Bookmark

                Author and article information

                Contributors
                Journal
                Lancet HIV
                Lancet HIV
                The Lancet. HIV
                Elsevier B.V
                2405-4704
                2352-3018
                27 June 2016
                July 2016
                27 June 2016
                : 3
                : 7
                : e297-e306
                Affiliations
                [a ]Bill & Melinda Gates Foundation, Seattle, WA, USA
                [b ]Department of Infectious Disease Epidemiology, Imperial College London School of Public Health, London, UK
                [c ]Biomedical Research and Training Institute, Harare, Zimbabwe
                [d ]London School of Hygiene & Tropical Medicine, London, UK
                [e ]AVAC, New York, NY, USA
                Author notes
                [* ]Correspondence to: Prof Geoffrey P Garnett, Bill & Melinda Gates Foundation, 500 Fifth Avenue North, Seattle, WA 98109, USACorrespondence to: Prof Geoffrey P GarnettBill & Melinda Gates Foundation500 Fifth Avenue NorthSeattleWA98109USA geoff.garnett@ 123456gatesfoundation.org
                Article
                S2352-3018(16)30039-X
                10.1016/S2352-3018(16)30039-X
                4935672
                27365204
                ff789cac-03ba-46c4-a5fb-b8eb94b71688
                © 2016 Garnett et al. Open Access article distributed under the terms of CC BY

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                Categories
                Articles

                Comments

                Comment on this article